Co-diagnostics, inc. to participate in 6th actc conference in skiathos, greece

Salt lake city , sept. 22, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq-cm: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that co-diagnostics will be hosting a booth and presenting at the 6th advances in circulating tumor cells ("actc") conference held this week in skiathos, greece.
CODX Ratings Summary
CODX Quant Ranking